- Precio de cierre del día anterior
260.46 - Apertura
258.41 - Oferta --
- Demanda 236.45 x 1200
- Rango diario
233.00 - 260.21 - Rango de 52 semanas
213.31 - 475.00 - Volumen
4,883,890 - Volumen prom.
2,493,363 - Capitalización bursátil (intradiario)
28.163MM - Beta (mensual por 5 años) 0.52
- Índice de relación precio/utilidad (últimos doce meses)
20.41 - EPS (últimos doce meses)
11.46 - Fecha de utilidades 23 ene 2025 - 27 ene 2025
- Proyección de dividendo y rentabilidad 3.54 (1.51%)
- Fecha de exdividendo 31 dic 2024
- Est. anual
288.80
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
www.humana.com67,600
Empleados a tiempo completo
31-diciembre
Fin del año fiscal
Sector
Industria
Noticias recientes: HUM
Más detallesInformación general del desempeño: HUM
Retornos totales acumulados hasta el 17/12/2024, que pueden incluir dividendos u otras distribuciones. El punto de referencia es
.Retorno a la fecha
Retorno en 1 año(s)
Retorno en 3 año(s)
Retorno en 5 año(s)
Comparar con: HUM
Puedes seleccionar hasta 4 acciones para analizar empresas similares utilizando métricas clave de rendimiento.
Estadísticas: HUM
Más detallesMedidas de valoración
Capitalización bursátil
28.16B
Valor de la empresa
36.07B
Precio/utilidad (últimos 12 meses)
20.41
Precio/beneficio estimado
13.57
Índice PEG (cálculo de 5 años)
1.07
Precio/Ventas (ttm)
0.25
Precio/reserva (TMR)
1.60
Valor de la empresa/Ingresos
0.31
Valor de la empresa/BAIIDA
--
Actividad financiera destacada
Rentabilidad y estado de resultados
Margen de ganancia
1.18%
Retorno de activos (ttm)
4.01%
Retorno sobre el capital (ttm)
7.84%
Ingresos (ttm)
115.01MM
Ingresos netos disponibles (ttm)
1.36MM
BPA diluido (ttm)
11.46
Balance general y flujo de efectivo
Caja total (TMR)
24.15MM
Deuda/capital total (TMR)
75.91%
Flujo de caja disponible apalancado (ttm)
-10.63MM